SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

2013 FDA drug approvals · Study

Work2013 FDA drug approvals

Asher Mullard2014

Work2014

2013 FDA drug approvals

97 citations·0/0 files stored·Nature Reviews Drug Discovery

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Regulation Pharmaceutical industry and healthcare

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 97 citations exist upstream.

Cited by

2014“New Drug” Designations for New Therapeutic Entities: New Active Substance, New Chemical Entity, New Biological Entity, New Molecular Entity 2025Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022)

Details

Year2014

Typeother

Published2014-01-31

VenueNature Reviews Drug Discovery

ISSN-L1474-1776

Languageen

Citations97

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1038/nrd4239

openalex_workW2759884156

Links

Imported from OpenAlex (CC0) — nothing here is generated.